PharmaCyte Biotech, Inc. (4)
Browse by Contract Category
Contracts
-
Amendment No. 3, dated as of October 14, 2020, to Executive Compensation Agreement between Gerald W. Crabtree and the Company
(Filed With SEC on October 16, 2020)
-
Amendment No. 1 to Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated July 15, 2020
(Filed With SEC on September 11, 2020)
-
Share Subscription Agreement between the Company and the Investor dated January 17, 2020
(Filed With SEC on January 21, 2020)
-
Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated May 4, 2020
(Filed With SEC on September 11, 2020)
